eutrophil Gelatinase Associated Lipocalin as a predictor of acute kidney injury post coronary angiogram

Not Applicable

Completed

• Conditions: Chronic Renal Disease; Urological and Genital Diseases; Chronic nephritic syndrome

• Registration Number: ISRCTN88709771
• Lead Sponsor: Randox Laboratories (UK)

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29069419 [added 18/01/2019]

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-03-13
• Study Completion: 2013-08-03
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Age > 18 years
2. Presenting for angiogram with known chronic kidney disease (CKD) [glomerular filtration rate (GFR) < 60mls/min]

Exclusion Criteria

1. Myocardial infarction (MI) or acute coronary syndrome within previous 6 weeks
2. Hospitalisation within previous 6 weeks
3. Decompensated heart failure
4. Inability to give informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post procedure biomarker elevation diagnostic for acute kidney injury

Secondary Outcome Measures

Name	Time	Method
<br> Major cardiac adverse events (MACE) at 30 days and one year:<br> 1. Myocardial infarction<br> 2. Stroke<br> 3. Heart failure hospitalisation<br> 4. Death<br>